NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lenoss Medical

Lenoss Medical

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://lenoss.com/

Last Round

VC Round

Mar 17, 2026

Total Funding Raised

$5.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lenoss Medical is a medical device company that has developed the OsteoPearl VBA System, a biologic, cement-free technology for treating vertebral compression fractures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biological allograftvertebral compression fractureskyphoplasty alternativebone graftspine surgeryminimally invasive surgerybone healingmedical devicebiologicscement-free implantorthobiologicsspine implantinterventional radiologyosteoporosis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lenoss Medical Comps

Public and private peers based on sector, stage, and business model.

Lenoss Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lenoss Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 17, 2026
Series AMay 9, 2024
SeedMay 5, 2021

Key People

Founding team and executive leadership

Dom Messerli

President & CEO

Executive Team

Lenoss Medical Investors

Notable investors and investment history

Lenoss Medical investors
InvestorRounds
Rouge VenturesSeries A
Vodia CapitalSeries A
Cherrystone Angel GroupSeries A, Seed
Magpie MedTech VenturesVC Round
Beacon AngelsSeed, VC Round
Walnut VenturesSeed
Highpoint VenturesSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Raised $6M in debt financing.

Lenoss Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lenoss Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lenoss Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersProvidence, Rhode Island
Employee Range12
Year Founded2017
Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.